|
CAS No. | 106308-44-5 |
Chemical Name: | Rufinamide |
Synonyms: | E 2080;RUF 331;Inovelon;CGP 33101;Rufinamide;RufinaMide(Banzel);Rufinamide solution;Rufinamide (200 mg);1-(2,6-Difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide;1H-1,2,3-TRIAZOLE-4-CARBOXAMIDE, 1-[(2,6-DIFLUOROPHENYL)METHYL]- |
CBNumber: | CB5972298 |
Molecular Formula: | C10H8F2N4O |
Formula Weight: | 238.1935264 |
MOL File: | 106308-44-5.mol |
|
|
|
|
Rufinamide Chemical Properties,Usage,Production |
Chemical Properties
White Solid |
|
Usage
Rufinamide, a triazole derivative, is an anticonvulsant medication. It is used in combination with other medication and therapy to treat Lennox–Gastaut syndrome and various other seizure disorders. Rufinamide is presumed to involve stabilization of the so |
|
Usage
Labelled Rufinamide (R701552). Antiepileptic triazole derivative which decreases firing by neurons at sodium channels. Anticonvulsant. |
|
Biological Activity
Board spectrum anticonvulsant. Prolongs the inactivation of sodium channels and limits the frequency of action potential firing in cultured and acutely isolated neurons. Displays anticonvulsive activity in a range of animal seizure models. |
|
|
Rufinamide Preparation Products And Raw materials |
Raw materials
|
Preparation Products
|
Rufinamide Suppliers Global( 70)Suppliers |
|
|
|
|
106308-44-5(Rufinamide)Related Search: |
Polyamide
CARBOXAMIDE
1,2,4-Triazole
1H-Benzotriazole
Acrylamide
Formamide
Acetamide
Boc-D-Glutamine
4-METHYL-1-PHENYLMETHYL-1H-1,2,3-TRIAZOLE
Rufinamide
CHLOANTRANILIPROLE
Nicotinamide
Poly(acrylamide)
Benzamide
N,N-Dimethylformamide
|
106308-44-5
1H-1,2,3-TRIAZOLE-4-CARBOXAMIDE, 1-[(2,6-DIFLUOROPHENYL)METHYL]-
1-(2,6-Difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
Rufinamide
Amines
Aromatics
Bases & Related Reagents
Heterocycles
Intermediates & Fine Chemicals
Nucleotides
Pharmaceuticals
Isotope Labelled Compounds
C10H6D2F2N4O
C10H6D2F2N315NO
Rufinamide (200 mg)
RufinaMide(Banzel)
CGP 33101
E 2080
Inovelon
RUF 331
Banzel
Rufinamide solution
|
Copyright 2016 © ChemicalBook. All rights reserved |